1 – 10 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease
- Contribution to journal › Article
- 2024
-
Mark
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
- Contribution to journal › Article
- 2023
-
Mark
The genetic regulation of protein expression in cerebrospinal fluid
- Contribution to journal › Article
-
Mark
Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease
- Contribution to journal › Article
- 2021
-
Mark
Reply to : Brain Amyloid Deposition in Late-Life Depression
- Contribution to journal › Letter
-
Mark
Models of Neuroimaging, Biomarkers, and Cognitive in Alzheimer's Disease. Implications for Clinical Trial Design.
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
- Contribution to journal › Article
-
Mark
The impact of amyloid burden and APOE on rates of cognitive impairment in late life depression
- Contribution to journal › Article
-
Mark
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
- Contribution to journal › Article
-
Mark
Time between milestone events in the Alzheimer's disease amyloid cascade
- Contribution to journal › Article
